Medifast, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 0K05.L | WW | FTLF | MEDPLUS.BO | MEGA.BK | 546.SI | |
|---|---|---|---|---|---|---|
| Market cap | — | 121.28M | 76.82M | 72.08B | 30.95B | 56.67M |
| P/E (TTM) | 0.9 | 0.1 | 13.2 | 34.1 | 14.2 | — |
| Forward P/E | — | -519.9 | 6.3 | 28.0 | 12.4 | — |
| Price/book | 0.8 | 0.4 | 1.6 | 3.4 | 3.0 | 0.4 |
| Dividend yield | — | — | — | — | 4.86% | — |
| 1-year change | +8.40% | −60.90% | −56.37% | −23.60% | +20.69% | −21.77% |
| Today | +3.61% | −6.55% | +3.68% | +0.02% | +1.43% | +7.22% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All 0K05.L news ›Medifast: 3 Key Takeaways for Long-Term Investors
Cost cuts and a metabolic health pivot must prove they can reignite growth before cash reserves deplete. On its third-quarter 2026 earnings call, held on Oct. 26, 2026, Medifast (MED +0.56%) reported revenue of $72 million for the quarter.…
Medifast Is Running The Same Playbook, And I Have The Same Concerns
Medifast maintains a strong, cash-heavy balance sheet and trades near liquidation value. Read more on MED stock and why it is a Hold. - Medifast (MED) maintains a strong, cash-heavy balance sheet and trades near liquidation value, but its…
Medifast Announces Third Quarter 2026 Financial Results
BALTIMORE--(BUSINESS WIRE)-- Medifast (MED) (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, today reported results for the third quarter ended September…
More from 1 other outlet
Medifast Non-GAAP EPS of -$0.19 beats by $0.16, revenue of $72.05M beats by $0.75M
Medifast Q3 earnings beat estimates despite a 19% revenue drop. - Medifast press release (MED): Q3 Non-GAAP EPS of -$0.19 beats by $0.16. - Revenue of $72.05M (-19.4% Y/Y) beats by $0.75M.
Medifast: Q3 Earnings Snapshot
BALTIMORE (AP) — BALTIMORE (AP) — Medifast Inc. (MED) on Monday reported a loss of $17.5 million in its third quarter. On a per-share basis, the Baltimore-based company said it had a loss of $1.57. Losses, adjusted for restructuring costs,…
Medifast Stock Analysis: 27.7% Decline Amid Weak Demand
Medifast has experienced a difficult six-month period, according to a report from Yahoo Finance. The company's stock price has fallen to $9.88, representing a decline of 27.7%. The analysis points to softer quarterly results as a…
Medifast Inc (NYSE:MED) Sees Significant Decrease in Short Interest
Posted by Sarita Garza on Oct 15th, 2026 Read Our Latest Analysis on MED The company’s programs combine nutrition products with guidance from independent OPTAVIA Coaches. These coaches provide accountability, support and lifestyle guidance…
Medifast Q3FY26 Results: Earnings call set for October 26
Medifast will announce its financial results for the third quarter ended September 30, 2026, on Monday, October 26, 2026, before market open. The metabolic health and wellness company will host a conference call to discuss the results and…
Can Medifast's Better Client Retention Support Revenue Stabilization?
This momentum was also evident at the company’s sold-out coach convention in July, which provided a clear indication of strong coach engagement. The strong referral program performance and renewed coach enthusiasm come as the company rolls…
Medifast, Inc. (MED) Q3 2026 Earnings Call Transcript
Medifast, Inc. (MED) Q3 2026 Earnings Call October 26, 2026 8:30 AM EDTCompany ParticipantsMatthew DarymanNicholas Johnson - CEO & PresidentJames... Medifast, Inc. (MED) Q3 2026 Earnings Call October 26, 2026 8:30 AM EDT James Salera -…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- seekingalpha.com5
- indexbox.io1
- scanx.trade1
- stocktitan.net1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.